« Back to results
  • Added 16 Apr 2013
  • Expires

Aeras - TB studies


Aeras is a nonprofit biotech advancing the development of tuberculosis vaccines for the world. In collaboration with global partners in Africa, Asia, North America and Europe, Aeras is supporting the clinical testing of six experimental vaccines as well as a robust portfolio of earlier stage candidates. Aeras and its partners are committed to conducting clinical studies under good clinical practices (GCP) and applying rigorous medical and ethical standards to its trials. Aeras is a fully integrated organization with capabilities in finance, portfolio management, and in-house capacity to conduct pilot manufacturing, immunology, assay development, clinical trials, regulatory affairs and policy, advocacy and resource mobilization. Aeras receives funding from the Bill & Melinda Gates Foundation, the UK Department for International Development, and the Netherlands’ Ministry of Foreign Affairs and a range of other governments. Aeras is based in Rockville, Maryland; Cape Town, South Africa; and Beijing, China.

Inclusion Criteria

TB patient populations worldwide


Aeras would be interested to hear from clinical research sites interested in working with us on future studies. Please contact us with your site profile information if you are would like to explore opportunities to collaborate.

Respond to this study

Please Login to respond to a study.